Please use this identifier to cite or link to this item:
|Title:||Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data|
|Authors:||Chow, Clara Kayei|
et al, Various
Mony, Prem K.
Western Clinical School: Medicine (Westmead)
|Publisher:||The Lancet Publishing Group|
|Citation:||Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data, The Lancet, vol.387, 10013, 2016,pp 61-69|
|Department/Unit/Centre:||Western Clinical School: Medicine (Westmead)|
|Disclaimer:||This work has been made available to the staff and students of the University of Sydney for the purposes of research and study only. It constitutes material that is held by the University for the purposes of reporting for HERDC and the ERA. This work may not be downloaded, copied and distributed to any third party .|
|Type:||C1 - Refereed Journal articles|
|Appears in Collections:||University of Sydney Research Outputs|
Items in Sydney Research Online are protected by copyright, with all rights reserved, unless otherwise indicated.